Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan
NCT03517982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2018-05-08
Summary
The purpose of this observational study was to assess the safety and efficacy of generic mycophenolate mofetil in de novo renal transplant patients in Jordan where no visits or intervention(s) additional to the daily practice were performed.
Conditions
- Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant
Interventions
- DRUG
-
Mycophenolate Mofetil
Film Coated Tablet, each tablet contains 500mg Mycophenolate Mofetil
Sponsors & Collaborators
-
Hikma Pharmaceuticals LLC
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
Countries
- Jordan
Study Locations
More Related Trials
-
A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)
NCT01822483 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients
NCT00239044 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients
NCT00239863 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil
NCT01672957 ·Status: COMPLETED
-
Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients
NCT00419926 ·Status: COMPLETED ·Phase: PHASE4
-
Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients
NCT00369278 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)
NCT00238979 ·Status: COMPLETED ·Phase: PHASE4
-
Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation
NCT03968588 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients
NCT00239083 ·Status: COMPLETED ·Phase: PHASE4
-
Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation
NCT00239005 ·Status: COMPLETED ·Phase: PHASE4
-
24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
NCT00555789 ·Status: TERMINATED ·Phase: PHASE2
-
MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
NCT06044493 ·Status: COMPLETED ·Phase: PHASE4
-
Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil
NCT00238966 ·Status: COMPLETED ·Phase: PHASE4
-
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
NCT01025817 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients
NCT00239070 ·Status: COMPLETED ·Phase: PHASE3
-
Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation
NCT00203671 ·Status: COMPLETED
-
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients
NCT00543569 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
NCT00239798 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients
NCT00617604 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
NCT00321113 ·Status: COMPLETED ·Phase: PHASE3
-
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302
NCT00149864 ·Status: COMPLETED ·Phase: PHASE3
-
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
NCT04207177 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant
NCT00099736 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
NCT01336296 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients
NCT00149903 ·Status: COMPLETED ·Phase: PHASE3